Silifat Jones-Ibrahim
Psychiatric/Mental Health · Homewood, ILNPI 1235850876
Payments from drug & device makers
Across 109 payments — averaging $20.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Otsuka America Pharmaceutical, Inc.$466
- Teva Pharmaceuticals USA, Inc.$428
- AbbVie$357
- Lundbeck LLC$257
- Alkermes, Inc.$177
- Johnson & Johnson$137
- plus $367 from 8 others
What the payments were for
- Food & beverage$2,09095%
- Education$1005%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 26 | $466 |
| Teva Pharmaceuticals USA, Inc. | 23 | $428 |
| AbbVie | 21 | $357 |
| Lundbeck LLC | 13 | $257 |
| Alkermes, Inc. | 6 | $177 |
| Johnson & Johnson | 5 | $137 |
| Axsome Therapeutics, Inc. | 4 | $102 |
| Neurocrine Biosciences, Inc. | 3 | $72 |
| Supernus Pharmaceuticals, Inc. | 2 | $47 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $45 |
| Indivior Inc. | 1 | $36 |
| Corium, LLC | 1 | $28 |
| Tris Pharma Inc | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
How this compares
$2,190 in reported general payments places this provider in the 80th percentile of 922 psychiatric/mental health providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Lurasidone Hcl | 13 | $5,006 |
| Olanzapine | 43 | $1,927 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 19 | $1,531 |
| Quetiapine Fumarate | 65 | $1,499 |
| Methylphenidate Er (La)Methylphenidate Hcl | 12 | $1,286 |
| Buspirone Hcl | 55 | $1,061 |
| Prazosin Hcl | 41 | $992 |
| Hydroxyzine Hcl | 30 | $973 |
| Ziprasidone Hcl | 12 | $960 |
| Methylphenidate Hcl | 19 | $888 |
| Alprazolam | 83 | $825 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 36 | $768 |
| Bupropion XlBupropion Hcl | 42 | $746 |
| Aripiprazole | 15 | $584 |
| Sertraline Hcl | 33 | $528 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Homewood
- Erin PetrusicChicago$517K
- Maurice BrownleeChicago$162K
- Melissa VitaleChicago$151K
- Alan AmbergChicago$119K
- Jaime MendozaMaryville$111K
- Jennifer TheryMaryville$83K
- Carole Weddington HuntGranite City$67K
- Jessica WhelanBloomington$55K
- Lynn LochnerKankakee$41K
- Julie CarbrayChicago$36K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.